CorMatrix ECM Technology has been used at more than 300 hospitals across the U.S. and has been implanted in nearly 20,000 cardiac procedures.

This naturally occurring extracellular matrix biomaterial supports native tissue repair by providing an interim bioscaffold, that enables a patient's own cells to repopulate and repair damaged tissues.

Watch how ECM Technology helps repair damaged heart tissue

September 12-15, 2010
Geneva, Switzerland
European Association for Cardio-Thoracic Surgery (EACTS) 24th Annual Meeting »

September 12-15, 2010
San Diego, CA
Heart Failure Society of America (HFSA) 14th Annual Scientific Meeting »

October 03-07, 2010
Washington, DC
American College of Surgeons 96th Annual Meeting »